A new research has found that Cannabis might not be the vilified 'gateway drug' it is widely thought to be.
In fact, the leafy substance might be the key to discouraging users from progressing to 'harder' drugs, such as cocaine and ecstasy, according to the scientists.
According to The Independent, the five-year-long study involved 125 participants, all of whom were suffering from chronic pain.
83 were taking cannabis as a prescriptive pain mediator, whereas 42 chose to abstain.
They found that 34 percent of the cannabis users stopped taking their medication, in comparison to just two per cent of the non-smokers, with 98 percent continuing to take their prescribed drugs.
Lead author and psychology professor Jacob Miguel Vigil, noted, "Our current opioid epidemic is the leading preventable form of death in the US, killing more people than car accidents and gun violence."
Adding, "Therefore, the relative safety and efficacy of using cannabis in comparison to that of other scheduled medications should be taken by the health providers and legislators."
He explained that painkillers and street heroin typically kill 90 people in the US every day; whereas some studies claim that cannabis consumption has never directly caused a fatality.
However, in 2014, a woman named Gemma Moss became the first British woman to die from cannabis toxicity, after she reportedly smoked GBP 60 worth of the drug in one week which led her to die from cardiac arrest.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
